AAC2_MYCFO
ID AAC2_MYCFO Reviewed; 195 AA.
AC Q49157;
DT 15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1996, sequence version 1.
DT 03-AUG-2022, entry version 74.
DE RecName: Full=Aminoglycoside 2'-N-acetyltransferase;
DE EC=2.3.1.-;
DE AltName: Full=AAC(2')-Ib;
GN Name=aac;
OS Mycolicibacterium fortuitum (Mycobacterium fortuitum).
OC Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC Mycolicibacterium.
OX NCBI_TaxID=1766;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=FC1K;
RX PubMed=8891143; DOI=10.1128/aac.40.10.2350;
RA Ainsa J.A., Martin C., Gicquel B., Gomez-Lus R.;
RT "Characterization of the chromosomal aminoglycoside 2'-N-acetyltransferase
RT gene from Mycobacterium fortuitum.";
RL Antimicrob. Agents Chemother. 40:2350-2355(1996).
CC -!- FUNCTION: Confers resistance to gentamicin, tobramycin, dibekacin,
CC netilmicin, and 6'-N-ethylnetilmicin.
CC -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC -!- SIMILARITY: Belongs to the AAC(2')-I acetyltransferase family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; U41471; AAC44793.1; -; Genomic_DNA.
DR RefSeq; WP_003881640.1; NZ_VHPZ01000010.1.
DR AlphaFoldDB; Q49157; -.
DR SMR; Q49157; -.
DR STRING; 1766.XA26_03650; -.
DR GeneID; 29426913; -.
DR KEGG; ag:AAC44793; -.
DR GO; GO:0008080; F:N-acetyltransferase activity; IEA:InterPro.
DR GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR InterPro; IPR000182; GNAT_dom.
DR SUPFAM; SSF55729; SSF55729; 1.
DR PROSITE; PS51186; GNAT; 1.
PE 3: Inferred from homology;
KW Acyltransferase; Antibiotic resistance; Transferase.
FT CHAIN 1..195
FT /note="Aminoglycoside 2'-N-acetyltransferase"
FT /id="PRO_0000064410"
FT DOMAIN 21..180
FT /note="N-acetyltransferase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00532"
FT BINDING 45
FT /ligand="substrate"
FT /evidence="ECO:0000250|UniProtKB:P9WQG9"
FT BINDING 92..93
FT /ligand="substrate"
FT /evidence="ECO:0000250|UniProtKB:P9WQG9"
FT BINDING 94..96
FT /ligand="CoA"
FT /ligand_id="ChEBI:CHEBI:57287"
FT /evidence="ECO:0000250|UniProtKB:P9WQG9"
FT BINDING 101..106
FT /ligand="CoA"
FT /ligand_id="ChEBI:CHEBI:57287"
FT /evidence="ECO:0000250|UniProtKB:P9WQG9"
FT BINDING 127
FT /ligand="substrate"
FT /evidence="ECO:0000250|UniProtKB:P9WQG9"
FT BINDING 161..162
FT /ligand="substrate"
FT /evidence="ECO:0000250|UniProtKB:P9WQG9"
SQ SEQUENCE 195 AA; 21343 MW; A19EC045210D549B CRC64;
MPFQDVSAPV RGGILHTARL VHTSDLDQET REGARRMVIE AFEGDFSDAD WEHALGGMHA
FICHHGALIA HAAVVQRRLL YRDTALRCGY VEAVAVREDW RGQGLATAVM DAVEQVLRGA
YQLGALSASD TARGMYLSRG WLPWQGPTSV LQPAGVTRTP EDDEGLFVLP VGLPAGMELD
TTAEITCDWR DGDVW